KAT2A and neoplasm: Notably, lysine acetyltransferase 2A (KAT2A) expression is markedly increased in clear cell renal cell carcinoma (ccRCC), where it likely promotes tumour metastasis and proliferation by modulating the immune‐suppressive tumour microenvironment.32